# FDA recall D-1124-2019

> **InvaGen Pharmaceuticals, Inc.** · Class II · drug recall initiated 2019-03-22.

## Product

Testosterone Cypionate Injection, USP, 200 mg/mL, For IM use only, 1 mL Vial, Single Dose, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc., 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL 33323, NDC 69097-537-31.

## Reason for recall

Presence of Particulate Matter.

## Distribution

Nationwide in the U.S.A.

## Key facts

- **Recall number:** D-1124-2019
- **Recalling firm:** InvaGen Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-03-22
- **Report date:** 2019-04-24
- **Termination date:** 2022-08-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Central Islip, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1124-2019

## Citation

> AI Analytics. FDA recall D-1124-2019. Retrieved 2026-06-08 from https://api.ai-analytics.org/recall/D-1124-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*